l-carnitine tmao koeth 2013 nature medicine Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease? Frontiers | TMAO as a
Frontiers TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review L Carnitine intake and high trimethylamine N oxide plasma levels correlate with low aortic lesions in ApoE transgenic mice expressing CETP ScienceDirect Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L Carnitine to TMAO ScienceDirect Frontiers The gut microbial metabolite trimethylamine N oxide and cardiovascular diseases Dietary allicin reduces transformation of L carnitine to TMAO through impact on gut microbiota ScienceDirect The microbial metabolite trimethylamine N oxide promotes antitumor immunity in triple negative breast cancer: Cell Metabolism
Pay in 4 interest-free payments of $7.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20





